Andreas Emmenegger
Director/Board Member bij LUZERNER KANTONALBANK AG
Oorsprong van het eerstegraads netwerk van Andreas Emmenegger
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Regional Banks | 29 | |
| Public Company | Biotechnology | 26 | |
Molecular Partners, Inc.
 Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The private company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Targimmune Therapeutics AG
 Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland.
8
| Holding Company | Pharmaceuticals: Major | 8 |
PIQUR Therapeutics AG
 PIQUR Therapeutics AG Pharmaceuticals: OtherHealth Technology PIQUR Therapeutics AG engages in development of anti-cancer drugs based on the inhibition. Its products include PQR309, PQR620 and PQR5xx. The company was founded by Bernd Giese, Vladimir Cmiljanovic, Andreas Emmenegger, Ralf Rosenow and Matthias Wymann in August 2011 and is headquartered in Basel, Switzerland.
5
| Holding Company | Pharmaceuticals: Other | 5 |
| Public Company | Industrial Machinery | 3 | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
| Private Company | Financial Conglomerates | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Andreas Emmenegger via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director of Finance/CFO | |
| COGENT BIOSCIENCES, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Credit Suisse AG
 Credit Suisse AG Investment ManagersFinance Credit Suisse AG is an investment management firm headquartered in Zurich, Switzerland. The firm was founded in 1856 and was acquired by UBS Group AG (SWX: UBSG) from Credit Suisse Group AG in 2023. Credit Suisse manages global and regional portfolios, mutual funds, and other investment vehicles for governments, institutions, corporations and individuals worldwide. They also offer private banking and wealth management, investment banking, and corporate and business support services. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BACHEM HOLDING AG | Pharmaceuticals: Major | Chairman Chief Operating Officer | |
| SCHWEIZERISCHE NATIONALBANK | Major Banks | Director/Board Member Corporate Officer/Principal | |
| University of Freiburg | College/University | Graduate Degree Undergraduate Degree | |
| Imperial College London | College/University | Corporate Officer/Principal Undergraduate Degree | |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Corporate Officer/Principal Corporate Officer/Principal | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer Director/Board Member | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Masters Business Admin | |
| University of St. Gallen | College/University | Graduate Degree Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
Chroma Therapeutics Ltd.
 Chroma Therapeutics Ltd. BiotechnologyHealth Technology Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Basel | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
| University of Zurich | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree Graduate Degree Doctorate Degree | |
| Swiss Federal Institute of Technology | College/University | Graduate Degree Corporate Officer/Principal Graduate Degree Masters Business Admin Doctorate Degree Graduate Degree Doctorate Degree Undergraduate Degree | |
| University of Bern | College/University | Masters Business Admin Doctorate Degree Doctorate Degree Masters Business Admin Graduate Degree | |
| SPEXIS AG | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Director/Board Member | |
KPMG Holding AG
 KPMG Holding AG Miscellaneous Commercial ServicesCommercial Services Part of KPMG International Cooperative, KPMG Holding AG is a Swiss company that provides accounting services. The private company is based in Zurich, Switzerland. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Essex Woodlands Health Ventures UK Ltd. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
Pro Juventute
 Pro Juventute Services to the Health IndustryHealth Services Pro Juventute is a Swiss company that provides information and tips for parents on various topics related to parenting. The private company's focus is on helping parents navigate the challenges of raising children and providing them with valuable resources to support their parenting journey. | Services to the Health Industry | Chairman Chairman | |
Zingg Lamprecht AG
 Zingg Lamprecht AG Specialty StoresRetail Trade Zingg Lamprecht AG is a Swiss company that specializes in interior design and offers extraordinary room concepts and design furniture for both private customers and companies. Zingg Lamprecht is based in Zurich, CH. The company has been a partner in this field since 1902 and provides individual and personal services. | Specialty Stores | Director/Board Member Director/Board Member | |
Jazz Pharmaceuticals UK Ltd.
 Jazz Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals UK Ltd. is pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, oncology supportive care and critical care products. The company was founded in 2006 and is headquartered in Oxford, United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Stiftung Konzerthaus Luzern | Director/Board Member Director/Board Member | ||
| Lucerne University of Applied Sciences & Arts | College/University | Undergraduate Degree Corporate Officer/Principal Graduate Degree Corporate Officer/Principal Masters Business Admin | |
| Institut Fur Finanzdienstleistungen Zug IFZ | Director/Board Member Chief Executive Officer | ||
Luzerner Kantonalbank AG (Private Banking)
 Luzerner Kantonalbank AG (Private Banking) Investment ManagersFinance Luzerner Kantonalbank AG (Private Banking) (LUKB-PB) is the private banking division of State of Lucerne-owned Luzerner Kantonalbank AG in Switzerland. Founded in 1850 as KantonaleSpar-und Leihkasse, the firm changed their name to Luzerner Kantonalbank in 1892. In 2006, they acquired private banking team Adler & Co. PrivatbankAG and in 2010 Adler & Co. PrivatbankAG merged into Luzerner Kantonalbank AG. LUKB-PB is based in Lucerne with an additional office in Zurich. They providesa full range of private banking services, including wealth management advice, for small and medium-sized enterprises in Canton Lucerne and the rest of German-speaking Switzerland. | Investment Managers | Chief Investment Officer Chief Executive Officer Head of Private Banking | |
| GSW Gemeinschaftsstiftung zur Erhaltung und Schaffung | Director/Board Member Director/Board Member | ||
| LUKB Wachstumskapital AG | Director/Board Member Director/Board Member | ||
Industrie und Handelskammer Zentralschweiz
 Industrie und Handelskammer Zentralschweiz Miscellaneous Commercial ServicesCommercial Services Industrie und Handelskammer Zentralschweiz (IHZ) is a business organization based in Lucerne, Switzerland. The IHZ is committed to the central Switzerland and supports export. The Swiss company designs economic policy and represent the optimal relationship interests to improve framework conditions. The IHZ networks the central Switzerland and offers various services such as export and service training, advice consulting, and more. The private company organizes around 15 events per year and have 4000 followers on social media. The IHZ has 722 member companies and 32 board members. The company uses cookies to make it easier for users to use their website. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Flaschenpost Services AG
 Flaschenpost Services AG Internet RetailRetail Trade Flaschenpost Services AG is a Swiss company that makes buying wine easy by offering free delivery for orders over 100 CHF and the largest range of wines in Switzerland. The private company is based in Switzerland and their website is available in both German and French. The company has over 2,500 wines immediately available for purchase. | Internet Retail | Director/Board Member Chairman | |
| Stiftung Best Art Collection | Director/Board Member Director/Board Member | ||
| Harvard Business School | College/University | Undergraduate Degree Masters Business Admin | |
Tessa Therapeutics Ltd
 Tessa Therapeutics Ltd BiotechnologyHealth Technology Tessa Therapeutics Pte Ltd. engages in the development and commercialization of cancer immunotherapies. The firm has recruitment sites in Singapore, Malaysia, Taiwan, Thailand and the United States. The company was founded by Malcolm Brenner and Andrew Khoo and is headquartered in Singapore. | Biotechnology | Chief Executive Officer Chairman | |
| SURFACE ONCOLOGY, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Investor Relations Contact | |
EUSA Pharma (UK) Ltd.
 EUSA Pharma (UK) Ltd. Medical DistributorsDistribution Services EUSA Pharma (UK) Ltd. supplies medicines and medical devices. It offers Caphosol, Xenazine, Collatamp, Custodiol, and Fomepizole. The company was founded in March 2015 and is headquartered in Hemel Hempstead, the United Kingdom. | Medical Distributors | Director/Board Member Director/Board Member | |
RSN Risk Solution Network AG
 RSN Risk Solution Network AG Miscellaneous Commercial ServicesCommercial Services Part of Basler Kantonalbank, RSN Risk Solution Network AG is a Swiss company that provides credit risk management services. The private company is based in Zurich, Switzerland. Markus Heusler has been the CEO of the company since 2004. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| IDORSIA LTD | Pharmaceuticals: Major | Director/Board Member General Counsel | |
Idorsia Pharmaceuticals Ltd.
 Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The private company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| swissVR | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal |
Statistieken
Internationaal
| Zwitserland | 28 |
| Verenigde Staten | 11 |
| Verenigd Koninkrijk | 6 |
| Nederland | 3 |
| Duitsland | 3 |
Sectoraal
| Health Technology | 21 |
| Consumer Services | 11 |
| Finance | 6 |
| Commercial Services | 5 |
| Retail Trade | 3 |
Operationeel
| Director/Board Member | 316 |
| Corporate Officer/Principal | 181 |
| Chairman | 107 |
| Chief Executive Officer | 64 |
| Independent Dir/Board Member | 51 |
Sterkste connecties
| Insiders | |
|---|---|
| Göran Albert Ando | 44 |
| Josef Anton Felder | 34 |
| Peter Morgan Kash | 32 |
| Steven Holtzman | 28 |
| William Burns | 27 |
| Martha Scheiber | 25 |
| Petri T. Vainio | 24 |
| Roger Studer | 22 |
| Markus Hongler | 21 |
| Stefan Portmann | 19 |
| Sandipkumar S. Kapadia | 19 |
| Doris Russi Schurter | 18 |
| Michael Vasconcelles | 17 |
| Paolo Fundarò | 17 |
| Dorothée Anna Deuring | 17 |
- Beurs
- Insiders
- Andreas Emmenegger
- Bedrijfsconnecties
